Highlights: Clinically proven effectiveness Offers stable, ongoing weight management Strong safety and tolerability record Ideal for ongoing, professionally supervised use How It Works: Acts as a GLP-1 receptor agonist, regulating insulin secretion and the hunger/anxiety feedback loop.
Discontinuing GLP-1 receptor agonist therapy leads to predictable physiological changes as drug levels decline and the pharmacological effects diminish
Enhances Glucose-Dependent Insulin Release Promotes insulin secretion in a glucose-dependent manner, helping manage blood sugar levels without unnecessary insulin release
The low-dose arm failed more decisively, with a hazard ratio of 0.931 and p=0.4661, essentially ruling out that regimen entirely
When these delicate systems become imbalanced due to genetics, environmental factors, or other underlying medical conditions, weight gain and obesity can occur